An earlier study (Borg et al., Am J Psychiatry 2003) found an inverse correlation between [carbonyl-11 C]WAY-100635 ligand binding to 5-HT 1A receptors and scores for self-transcendence, but no other of the six dimensions of the Temperament and Character Inventory, in a group of healthy males. The aim of this study was to investigate if the finding of an inverse correlation between spirituality and 5-HT 1A could be seen in patients suffering from major depressive disorder or replicated among healthy volunteers. A total of 23 patients with major depressive disorder and 20 healthy volunteers were examined with PET using [carbonyl-11 C]-WAY-100635 as the radioligand. The personality traits were measured using the Finnish version of the Temperament and Character Inventory and correlated with ligand binding (BP). No significant correlations were found between the different Temperament and Character Inventory subscales and BP in any of the studied brain regions (amygdala, anterior cingulate cortex, dorsal raphe nuclei, dorsolateral prefrontal cortex, angular gyrus, inferior, middle, and superior temporal gyri, medial prefrontal cortex orbitofrontal cortex, hippocampus, insular cortex, subgenual anterior cingulate cortex, supramarginal gyrus, ventrolateral prefrontal cortex, and posterior cingulate cortex). These results do not support the idea that the serotonin system forms the biological basis of spiritual experiences among patients suffering from major depressive disorder or among healthy volunteers.
Introduction
In an earlier study 1 it was found that the binding potential (BP ND , ratio of specifically bound ligand to free and non-specifically bound ligand) of [carbonyl- 11 C]WAY-100635, a ligand for 5-HT 1A receptors, correlated inversely with scores for self-transcendence, but no other of the six dimensions of the Temperament and Character Inventory, in a group of healthy males.
There is some evidence showing that patients suffering from depression score higher in self-transcendence compared with healthy subjects 2, 3 and that 5-HT 1A receptor availability is lower among patients suffering from major depressive disorder. 4, 5 At the same time, there seems to be no correlation between the severity of depressive symptoms and BP ND.
4,5
Thus, low 5-HT 1A BP ND may reflect a trait-like vulnerability and the high self-transcendence a stable personality trait.
In this study, we sought to determine whether the previously reported finding of a negative correlation between spirituality and 5-HT 1A binding could also be seen in patients suffering from major depressive disorder and replicated among healthy volunteers. Our hypothesis was that the same pattern between spirituality and 5-HT 1A binding could be found among depressive patients and healthy volunteers as was found among healthy men by Borg et al. 
Methods
We assessed the association between self-transcendence and 5-HT 1A in a sample of patients with major depressive disorder that we demonstrated earlier having lower 5-HT 1A receptor binding (BP P ) than healthy subjects. 5 Of the 25 patients described in our earlier report, Temperament and Character Inventory data were available from 23 patients (10 males, 13 females, age 40 ± 9 years). In this subsample, Hamilton depression rating scale scores ranged from 13 to 23 (median 18) and total Beck depression inventory scores ranged from 10 to 40 (median 23). A total of 22 patients were completely antidepressant-naive, and 1 patient had been treated with citalopram 5 years before the imaging and was free of antidepressant drug therapy since. Arterial plasma data were available for 19 of these patients (for estimating BP P ). In addition, we included 20 healthy subjects (11 males, 9 females, age 26±6 years). Each study subject also underwent 1.5 T magnetic resonance imaging.
This study was approved by the Joint Ethical Committee of the University of Turku and Turku University Central Hospital, and was conducted according to the Declaration of Helsinki. After complete description of the study to the subjects, written informed consent was obtained.
Positron emission tomography procedures
Positron emission tomography experiments were carried out as described earlier. 6 Injected dose and mass was 236 ± 28 MBq and 1.1 ± 0.7 mg for patients with major depressive disorder, and 252 ± 80 MBq and 2.0±0.9 mg for healthy controls, respectively (means ± s.d.). Arterial plasma samples were collected for the measurement of plasma radioactivity and metabolites according to earlier published schedule, 6 and an arterial plasma input curve for [carbonyl-
11 C]WAY 100635 corrected for metabolites was constructed.
Automated region of interest analysis PET images were analyzed using an automated region of interest analysis as described earlier. 5 In brief, summed (integral) PET images were spatially normalized to a ligand-specific template in the standard stereotactic space using SPM2. 7 These transformation parameters were then applied to dynamic PET images, and a set of regions of interest in the stereotactic were applied to the normalized dynamic PET images to calculate regional time-activity curves. Regions covered the following brain regions: amygdala, anterior cingulate cortex, dorsal raphe nuclei, dorsolateral prefrontal cortex, angular gyrus, inferior, middle, and superior temporal gyri, medial prefrontal cortex, orbitofrontal cortex, hippocampus, insular cortex, subgenual anterior cingulate cortex, supramarginal gyrus, ventrolateral prefrontal cortex, and posterior cingulate cortex.
Quantification of [carbonyl-
11 C]WAY-100635 binding Distribution volume (V T ) was estimated as described earlier. 6 V T represents the ratio at equilibrium of area under the curve in the brain to that in arterial plasma; 8 that is, it corrects the observed brain activity with that observed in arterial plasma. BP values were estimated indirectly from V T values as the ratio of specifically bound ligand either to total ligand in arterial plasma (BP P ) or to free plus non-specifically bound ligand in tissue (BP ND ). 8 BP P was calculated using cerebellar white matter as reference region. 5, 6 BP P is preferred over BP ND for estimating specific binding of [carbonyl- 11 C]WAY-100635 because of its Serotonin and spirituality H Karlsson et al relative independence of changes in non-specific binding. 5, 6 BP ND was calculated with the simplified reference tissue model 9 using cerebellar gray matter as the reference region to enable direct comparison with an earlier study. 1 
Statistical analyses
Analyses were performed on the natural logarithm of BP P . 5 The association between Temperament and Character Inventory components and BP P or BP ND was evaluated with Pearson's correlation coefficients (R), to enable direct comparison to an earlier study. 1 P < 0.05 was considered statistically significant. Correlation coefficients from this study were compared with those from Borg et al.
1 using z-transformation of R values.
Results
Self-transcendence scores ranged from 7 to 32 (median 25) in patients with major depressive disorder and from 18 to 32 (median 25) in the healthy subjects. However, this inter-individual variability was not explained by variability in 5-HT 1A receptor binding, as no significant correlations were seen between total self-transcendence scores and BP P in any of the brain regions in patients with major depressive disorder (R = 0.16-0.38, P = 0.11-0.53) or in healthy subjects (R = 0.02-0.20, P = 0.11-0.94) ( Table 1 and Figure 1 ). All 95% confidence intervals for correlation coefficients included 0; for example, these intervals for neocortical BP P and self-transcendence were from À0.17 to 0.66 in patients with major depressive disorder and from À0.36 to 0.52 in healthy subjects. No correlations emerged with other Temperament and Character Inventory components or selftranscendence sub-scores (data not shown).
BP ND values were also estimated to enable direct comparison with correlation coefficients reported by Borg et al. 1 There were no significant correlations between total self-transcendence scores and BP ND in the patients (neocortex: R = À0.10, P = 0.64, hippocampus: R = À0.18, P = 0.40, raphe: R = 0.05, P = 0.82) or in the healthy subjects (neocortex: R = 0.42, P = 0.06, hippocampus: R = 0.31, P = 0.18, raphe: R = À0.04, P = 0.88). When we compare the correlation coefficient for neocortical BP ND and self-transcendence in healthy subjects in this study (R = 0.42) to that reported by Borg et al. (R = À0.59), we can conclude that these values are significantly different (z = 2.99, P = 0.003, two-tailed)-suggesting that the observed data are very unlikely to occur under the null hypothesis that the results of the two studies are the same. There were no differences between the genders in the relationship between self-transcendence scores and 5-HT 1A binding.
Discussion
Self-transcendence did not correlate with 5-HT 1A receptor binding either in patients with major depressive disorder on in healthy subjects. This finding was contrary to our primary hypothesis. There are several possible reasons for this. First, the relationship between spirituality and the serotonin system is more complex than in the finding in Borg et al. 1 Religiosity may protect from depression 10 and this may have resulted in a situation in which our sample did not contain the ones with high religious beliefs. This suggestion, however, is implausible because the range of self-transcendence scores in our sample was 7-32, whereas in Borg et al. 1 it was 3-15. There is also evidence that some forms of religiosity even increases the risk for depression.
11
This latter stance could be partially supported by the fact that depressive subjects have higher scores on the self-transcendence scale of the Temperament and Character Inventory, 3 which is the most stable of the dimensions. 12 Patients suffering from major depressive disorder could, thus, also be different from healthy subjects in the relationship between spirituality and the serotonin system. However, our study did not find any significant correlations between 5-HT 1A binding and self-transcendence in either of the two groups. The strengths of this study are a larger sample size and wider distribution of self-transcendence scores than in Borg et al., 1 and a more strict methodology using arterial plasma samples. Moreover, the possibility that drug treatment accounts for the result is improbable because all patients were practically drugnaive. One limitation is that the patients were mildly to moderately depressed, thus reflecting the mild end of the spectrum of major depressive disorder. Another limitation is that though the sample size was larger than that of Borg et al.,
1 it was still small in the face of the large variability associated with complex phenotypic traits. The latter limitation is unfortunately shared by many PET neuroreceptor studies, and larger samples, perhaps with pooled data across different sites, are clearly called for to avoid inconsistent findings.
